InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Wheadon David E., Director. Director active across 6 companies, notably Indivior Pharmaceuticals, Inc.. Cumulatively, 15 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €54k. Activity tracked since 28 May 2021. The latest transaction was disclosed on 16 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Wheadon David E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
39,400 股0Common StockSEC:0001437749-26-023807:0
10,430 股0Common StockSEC:0001789507-26-000008:0
5,955 股0Common StockSEC:0001789507-26-000006:0
1,771 股@ US$35.3926100.0% 占其流量Ordinary SharesSEC:0001789507-26-000004:0
标准退出：2026年4月5日 (T+90)
16,000 股0Common StockSEC:0001437749-25-020569:0
19,132 股0Common Stock, $0.01 par value per share ("Common Stock")SEC:0000950170-25-077809:0
16,000 股0Common StockSEC:0001437749-24-020098:0
20,089 股0Common Stock, $0.01 par value per share ("Common Stock")SEC:0000950170-24-066020:0
990 股@ US$330.00100.0% 占其流量Common StockSEC:0001140361-24-013935:0
7,375 股0Common StockSEC:0001437749-23-021501:0
990 股0Common StockSEC:0000950170-23-029416:0
15,712 股0Common Stock, $0.01 par value per share (Common Stock)SEC:0001209191-23-033161:0
7,375 股0Common StockSEC:0001437749-22-019442:0
10,643 股0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001822479-22-000038:0
9,336 股0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001822479-21-000044:0
15 条申报中的 15 条
About Wheadon David E.
David E. Wheadon is a Board Member at Indivior Pharmaceuticals, Inc. and Sotera Health Co. He brings expertise in corporate governance and strategy. His role on the board is essential in guiding the strategic decisions of the companies.
